Epidemiology of hepatitis C virus infection in highly endemic HBV areas in China
- PMID: 23372775
- PMCID: PMC3555996
- DOI: 10.1371/journal.pone.0054815
Epidemiology of hepatitis C virus infection in highly endemic HBV areas in China
Abstract
Background: Wuwei City has the highest prevalence of hepatitis B virus (HBV) in China. From 2007 to 2011, the average reported incidence rate of hepatitis B was 634.56/100,000 people. However, studies assessing the epidemic features and risk factors of HCV in the general population of Wuwei City are limited.
Methods: A total of 7189 people were interviewed and screened for HCV antibodies. HCV RNA and HCV genotypes were analyzed by PCR. Relevant information was obtained from the general population using a standardized questionnaire, and association and logistic regression analyses were conducted.
Results: The anti-HCV prevalence was 1.64% (118/7189), and HCV-RNA was detected in 37.29% (44/118) of the anti-HCV positive samples. The current HCV infection rate was 0.61% (44/7189) in the Wuwei general population. Hepatitis C infection rate was generally higher in the plains regions (χ(2) = 27.54,P<0.05), and the most predominant HCV genotypes were 2a (59.1%) and 1b (34.1%). The concurrent HCV and HBV infection rate was 1.37%, and a history of blood transfusion (OR = 17.9, 95% CI: 6.1 to 52.6, p<0.001) was an independent risk factor for HCV positivity.
Conclusions: Although Wuwei is a highly endemic area for HBV, the anti-HCV positive rate in the general population is low. More than one-third of HCV-infected people were unaware of their infection; this may become an important risk factor for hepatitis C prevalence in the general population. Maintaining blood safety is important in order to help reduce the burden of HCV infection in developing regions of China.
Conflict of interest statement
Figures
Similar articles
-
Epidemiological distribution and genotype characterization of hepatitis C virus and HIV co-infection in Wuhan, China, where the prevalence of HIV is low.J Med Virol. 2013 Oct;85(10):1712-23. doi: 10.1002/jmv.23650. Epub 2013 Jul 19. J Med Virol. 2013. PMID: 23868809
-
Hepatitis B virus and hepatitis C virus infection among HIV-1-infected injection drug users in Dali, China: prevalence and infection status in a cross-sectional study.Arch Virol. 2015 Apr;160(4):929-36. doi: 10.1007/s00705-014-2311-0. Epub 2015 Jan 24. Arch Virol. 2015. PMID: 25616842
-
Prevalence of hepatitis B virus and hepatitis C virus in patients with human immunodeficiency virus infection in Central China.Arch Virol. 2013 Sep;158(9):1889-94. doi: 10.1007/s00705-013-1681-z. Epub 2013 Apr 4. Arch Virol. 2013. PMID: 23553454
-
Update on epidemiology of hepatitis B and C in China.J Gastroenterol Hepatol. 2013 Aug;28 Suppl 1:7-10. doi: 10.1111/jgh.12220. J Gastroenterol Hepatol. 2013. PMID: 23855289 Review.
-
Hepatitis C Virus in mainland China with an emphasis on genotype and subtype distribution.Virol J. 2017 Feb 23;14(1):41. doi: 10.1186/s12985-017-0710-z. Virol J. 2017. PMID: 28231805 Free PMC article. Review.
Cited by
-
Prevalence of antibodies to hepatitis C virus in voluntary blood donors: are women better donors?J Clin Diagn Res. 2014 Apr;8(4):DC20-3. doi: 10.7860/JCDR/2014/7575.4295. Epub 2014 Apr 15. J Clin Diagn Res. 2014. PMID: 24959444 Free PMC article.
-
Hepatitis C virus genotype and subtype distribution in Chinese chronic hepatitis C patients: nationwide spread of HCV genotypes 3 and 6.Virol J. 2015 Jul 25;12:109. doi: 10.1186/s12985-015-0341-1. Virol J. 2015. PMID: 26206422 Free PMC article. Clinical Trial.
-
Vertical transmission of hepatitis C virus: Current knowledge and perspectives.World J Hepatol. 2014 Sep 27;6(9):643-51. doi: 10.4254/wjh.v6.i9.643. World J Hepatol. 2014. PMID: 25276280 Free PMC article. Review.
-
Genetic variation in interleukin 28B and response to antiviral therapy in patients with dual chronic infection with hepatitis B and C viruses.PLoS One. 2013 Oct 17;8(10):e77911. doi: 10.1371/journal.pone.0077911. eCollection 2013. PLoS One. 2013. PMID: 24147097 Free PMC article.
-
Extracellular vesicles in bacterial and fungal diseases - Pathogenesis to diagnostic biomarkers.Virulence. 2023 Dec;14(1):2180934. doi: 10.1080/21505594.2023.2180934. Virulence. 2023. PMID: 36794396 Free PMC article. Review.
References
-
- Williams R (2006) Global challenges in liver disease. Hepatology 44: 521–6. - PubMed
-
- Awadalla HI, Ragab MH, Nassar NA, Osman MA (2011) Risk factors of hepatitis C infection among Egyptian blood donors. Cent Eur J Public Health 19: 217–21. - PubMed
-
- Busch MP (2001) Insights into the epidemiology, natural history and pathogenesis of hepatitis C virus infection from studies of infected donors and blood product recipients. Transfus Clin Biol 8: 200–6. - PubMed
-
- Li Jie, Zhuang Hui (2012) The epidemiological progression of hepatitis. Chinese Hepatology 17: 2–5.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical